U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187621187621Vaccine Therapy in Treating Patients With Kidney CancerActive, not recruitingNo Results AvailableKidney CancerBiological: human prostate-specific membrane antigen plasmid DNA vaccine|Biological: mouse prostate-specific membrane antigen plasmid DNA vaccinehttps://ClinicalTrials.gov/show/NCT00096629
187622187622Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe AsthmaCompletedNo Results AvailableAsthmaDrug: Combivent® CFC MDI|Drug: Albuterol HFA MDIhttps://ClinicalTrials.gov/show/NCT00096616
187623187623A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600gCompletedNo Results AvailablePsoriasisDrug: Raptiva (efalizumab)https://ClinicalTrials.gov/show/NCT00096603
187624187624Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing SurgeryCompletedNo Results AvailableThromboembolism|Unspecified Adult Solid Tumor, Protocol SpecificOther: coagulation study|Other: immunoenzyme technique|Other: laboratory biomarker analysis|Other: physiologic testing|Procedure: study of high risk factorshttps://ClinicalTrials.gov/show/NCT00096590
187625187625Brain Activities Associated With Different Facial Expressions Using Blood Oxygenation Level Dependent Functional MRICompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00096564
187626187626A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive TherapyCompletedNo Results AvailableProstatic NeoplasmsDrug: Recombinant Vaccinia-PSA(L155)/TRICOM (PROSTVAC-V/TRICOM)|Drug: Recombinant Fowlpox-PSA(L155)/TRICOM (PROSTVAC-F/TRICOM)|Drug: Recombinant Fowlpox-GM-CSFhttps://ClinicalTrials.gov/show/NCT00096551
187627187627Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's SarcomaCompletedNo Results AvailableSarcomaDrug: valganciclovirhttps://ClinicalTrials.gov/show/NCT00096538
187628187628Lenalidomide in Treating Patients With Advanced or Unresectable Kidney CancerCompletedNo Results AvailableKidney CancerDrug: lenalidomidehttps://ClinicalTrials.gov/show/NCT00096525
187629187629S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNo Results AvailableMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell CarcinomDrug: sorafenib tosylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00096512
187630187630SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or PaclitaxelCompletedNo Results AvailableAdenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage IV Prostate CancerDrug: ispinesib|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00096499
187631187631Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: everolimus|Drug: gefitinibhttps://ClinicalTrials.gov/show/NCT00096486
187632187632Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's Disease|DementiaDrug: Donepezil hydrochloridehttps://ClinicalTrials.gov/show/NCT00096473
187633187633Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)TerminatedHas ResultsRecurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Follicular LymphomaDrug: Cyclophosphamide and Rituximab|Drug: Filgrastim|Radiation: Chemotherapy or Radiation therapy|Drug: Non-myeloablative Conditioning regimen|Procedure: Allogeneic transplant|Procedure: Autologous transplant|Drug: Rituximab maintenance therapy|Drug: GVHD Prophylaxishttps://ClinicalTrials.gov/show/NCT00096460
187634187634Lapatinib in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedHas ResultsRecurrent Endometrial CarcinomaDrug: lapatinib ditosylatehttps://ClinicalTrials.gov/show/NCT00096447
187635187635Sorafenib in Treating Patients With Metastatic Breast CancerCompletedNo Results AvailableMale Breast Cancer|Recurrent Breast Cancer|Stage IV Breast CancerDrug: sorafenib tosylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00096434
187636187636Tight Glycemic Control in Critical Care PatientsCompletedNo Results AvailableCritical Illness|Hyperglycemia|Insulin ResistanceBehavioral: Tight control of blood glucose levels|Behavioral: Conventional control of glucose levelshttps://ClinicalTrials.gov/show/NCT00096421
187637187637Laparoscopic Approach to Cancer of the EndometriumActive, not recruitingNo Results AvailableEndometrial CancerProcedure: Total Abdominal Hysterectomy|Procedure: Total Laparoscopic Hysterectomyhttps://ClinicalTrials.gov/show/NCT00096408
187638187638Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian CancerCompletedNo Results AvailableRecurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity CancerDrug: gemcitabine hydrochloride|Drug: sorafenib tosylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00096395
187639187639Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedHas ResultsMelanoma (Skin)Biological: aldesleukin|Biological: filgrastim|Biological: therapeutic tumor infiltrating lymphocytes|Drug: cyclophosphamide|Drug: fludarabine phosphate|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00096382
187640187640Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: tamoxifen citratehttps://ClinicalTrials.gov/show/NCT00096369
187641187641Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast CancerCompletedHas ResultsBreast Cancer|FatigueDietary Supplement: CoQ10 & Vitamin E|Dietary Supplement: Placebo & Vitamin Ehttps://ClinicalTrials.gov/show/NCT00096356
187642187642Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast CancerCompletedNo Results AvailableBreast CancerDrug: carboplatin|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00096343
187643187643Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal CancerCompletedNo Results AvailableColorectal CancerDietary Supplement: dietary intervention|Dietary Supplement: folic acidhttps://ClinicalTrials.gov/show/NCT00096330
187644187644Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid TumorsActive, not recruitingNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: ixabepilone|Drug: ketoconazolehttps://ClinicalTrials.gov/show/NCT00096317
187645187645Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNo Results AvailableProstate CancerDrug: docetaxel|Drug: epirubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00096304
187646187646Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast CancerActive, not recruitingNo Results AvailableBreast CancerOther: Doxorubicin followed by Paclitaxel|Other: Paclitaxel followed by Doxorubicinhttps://ClinicalTrials.gov/show/NCT00096291
187647187647Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon CancerCompletedHas ResultsAdenocarcinoma of the Colon|Stage IIA Colon Cancer|Stage IIB Colon Cancer|Stage IIC Colon Cancer|Stage IIIA Colon Cancer|Stage IIIB Colon Cancer|Stage IIIC Colon CancerDrug: oxaliplatin|Drug: leucovorin calcium|Drug: fluorouracil|Biological: bevacizumabhttps://ClinicalTrials.gov/show/NCT00096278
187648187648Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung CancerTerminatedHas ResultsRecurrent Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer|Tumors Metastatic to BrainDrug: erlotinib hydrochloride|Radiation: 3-dimensional conformal radiation therapy|Radiation: stereotactic radiosurgery|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT00096265
187649187649CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: CP-547,632https://ClinicalTrials.gov/show/NCT00096239
187650187650Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung CancerCompletedHas ResultsLung CancerDrug: Induction Carboplatin|Drug: Induction Paclitaxel|Procedure: Resection|Drug: Consolidation Carboplatin|Radiation: Radiation Therapy|Drug: Consolidation Paclitaxelhttps://ClinicalTrials.gov/show/NCT00096226

* Görseller ve İçerik tekif hakkına sahip olabilir